Back to Search
Start Over
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
- Source :
-
Respiratory Research . 7/11/2020, Vol. 21 Issue 1, p1-3. 3p. - Publication Year :
- 2020
-
Abstract
- Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14659921
- Volume :
- 21
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Respiratory Research
- Publication Type :
- Academic Journal
- Accession number :
- 144520777
- Full Text :
- https://doi.org/10.1186/s12931-020-01439-4